Related Experiment Videos
Divergence in activation by poly I:C of human natural killer and killer cells
Cancer Immunology, Immunotherapy : CII
|January 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
The CREM-IL-15 axis: decoding the persistence-exhaustion paradox in NK cell immunotherapy.
Cancer immunology, immunotherapy : CII·2026
Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma.
Cancer immunology, immunotherapy : CII·2026
Mast cells in tumors: dual roles and therapeutic potential.
Cancer immunology, immunotherapy : CII·2026
Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma.
Cancer immunology, immunotherapy : CII·2026
HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression.
Cancer immunology, immunotherapy : CII·2026